D-0442-2024 Class I Terminated

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-0442-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Mar 21, 2024 and is designated Class I. Reason for recall: Superpotent Drug: Due to overfilling of drug powder The recall status is terminated (terminated Jul 21, 2025). Affected quantity: 821 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 24, 2024
Initiation Date
Mar 21, 2024
Termination Date
Jul 21, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
821 bottles

Product description

Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 150 mL bottle, NDC 69238-2261-7; (c)300 mL bottle, NDC 69238-2261-5; Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807

Reason for recall

Superpotent Drug: Due to overfilling of drug powder

Distribution pattern

Nationwide in the USA.

Code information

Lot # (a) 22613003A, Exp. date 09/30/2025; (b) 22613004A, 22613005A, Exp. date 09/30/2025; (c) 22613005B, Exp. date 09/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0442-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0442-2024. Report a data issue: hello@regdatalab.com.